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ABSTRACT 
Drug delivery via the oral mucous membrane is considered to be a promising alternative to the oral route. Sublingual route is a useful when rapid 
onset of action is desired with better patient compliance than orally administered drugs. In terms of permeability, the sublingual area of the oral 
cavity is more permeable than the buccal area, which in turn is more permeable than the roof of the mouth area. The portion of drug absorbed 
through the sublingual blood vessels avoids hepatic first‐pass metabolic processes giving good bioavailability. Sublingual technology for patients 
need enhanced lifecycle management to convenient dosing forgeriatric, pediatric and patient with dysphagia. This review highlights the 
introduction of sublingual drug delivery,mechanism ,factors affecting sublingual absorption, advantages, disadvantages,methods of 
preparation(tablet,films),drug administered by this route and conclusion. 
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INTRODUCTION 
Systemic drug delivery through the sublingual route had 
emergedfrom the desire to provide immediate onset of 
pharmacological effect. Dysphagia (difficulty in swallowing) 
is a common problem of all age groups, especially elderly, 
children, and patients who are mentally retarted, uncooperative, 
nauseated or on decreased liquidintake/ diets have difficulties 
in swallowing these dosage forms1. Sublingual 
administration of the drug means placement of the drug under 
the tongue and drug reaches directly in to the blood stream 
through the ventral surface of the tongue and floor of the mouth. 
The drug solutes are rapidly absorbed into the reticulated 
vein which lies underneath the oral mucosa, and transported 
through the facial veins, internal jugular vein, and braciocephalic 
vein and then drained in to systemic circulation2. The main 
mechanism for the absorption of the drug in to oral mucosa is via 
passive diffusion into the lipoidal membrane3. The absorption 
of the drug through the sublingual route is 3 to 10 times greater 
than oral route and is only surpassed by hypodermic 
injection. For these formulations, the small volume of saliva is 
usually sufficient to result in tablet disintegration in the oral 
cavity 
MECHANISM OF SUBLINGUAL DRUG DELIVERY 
The absorption potential of the buccal mucosa is affected by 
the lipid solubility and hence the permeability of the solution , the 
ionization (pH), and the molecular weight of the substances. For 
example, absorption of some drugs via the buccal mucosa is 
shown to increase when carrier pH is lowering (more acidic) 
and decrease with a lowering of pH (more alkaline).4,5 
The absorption is effected by the lipid solubility and hence the 
permeability of the solution commonly known as osmosis, the 
ionization, and the molecular weight of the drug. The cells of oral 
epithelium adsorb the drug by the process of endocytocis. It is 
unlikely that the same mechanism is observed throughout the 
stratified epithelium. However, it is believed that acidic 
stimulation of the salivary glands, with the accompanying 
vasodilatation, facilitates absorption and uptake into the 
circulatory system. The mouth is lined with a mucous 
membrane which is covered with squamous epithelium and 
contains mucous glands. The sublingual mucosal tissue is 
similar to that of buccal mucosa6,7 The salivary glands consist 
of lobules of cells which secrete saliva through the salivary 
ducts into the mouth. The three pairs of salivary glands are the 
parotid, the submandibular and the sublingual which lies on 
the floor of the mouth. The more acidic the taste is, greater the 
stimulation of salivary output; serving to avoid potential harm to 
acid‐sensitive tooth enamel by bathing the mouth in copious 
neutralizing fluid. The sublingual artery travels forward to the 
sublingual gland, it supplies the gland and branches to the 
neighboring muscles and to the mucous membranes of the 
mouth, tongue and gums. 
Two symmetrical branches travel behind the jawbone under the 
tongue to meet and join at its tip. Another branch meets and 
anastomoses with the submental branches of the facial artery. 
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The sublingual artery stems from the lingual artery – the body's 
main blood supply to the tongue and the floor of the mouth 
– which arises from the external carotid artery. The 
proximity with the internal carotid artery allows fast access to its 
route supplying the greater part of the cerebral hemisphere 8,9. 
FACTORS AFFECTING THE SUBLINGUAL 
ABSORPTION10 
1. Lipophilicity of drug: For a drug to be absorbed completely 
through sublingual route, the drug must have slightly 
higher lipid solubility than that required for GI 
absorption is necessary for passive permeation. 
2. Solubility in salivary secretion: In addition to high lipid 
solubility, the drug should be soluble in aqueous buccal 
fluids i.e. biphasic solubility of drug is necessary for 
absorption. 
3. pH and pKa of the saliva: As the mean pH of the saliva is 6.0, 
this pH favors the absorption of drugs which remain 
unionized. Also, the absorption of the drugs through the oral 
mucosa occurs if the pKa is greater than 2 for an acid and 
less than 10 for a base. 
4. Thickness of oral epithelium: As the thickness of 
sublingual epithelium is 100‐200 μm which is less as 
compared to buccal thickness. So the absorption of drugs 
is faster due to thinner epithelium and also the immersion 
of drug in smaller volume of saliva. 
5. partition coefficient: Compounds with favorable oilto‐ 
water partition coefficients are readily absorbed through 
the oral mucosa. An oil‐water partition coefficient range of 
40‐2000 is considered optimal for the drugs to be absorbed 
sublingually. 
 
ADVANTAGES OF SUBLINGUAL DRUG DELIVERY 
SYSTEM 
 Easy to administered to the patients who are unable to 
swallow a tablet, such as pediatric, geriatric patients and 
psychiatric patients. 
 A relatively fast action can be achieved compared to the 
oral route. 
 The large contact surface of the oral cavity contributes to 
rapid and extensive drug absorption. 
 First pass metabolism is avoided and the drug is 
protected from degradation due to pH and digestive 
enzymes of the middle gastrointestinal tract. 
 They also present the advantage of providing fast 
dissolution or disintegration in the oral cavity, without the 
need for water or chewing. 
DISADVANTAGES OF SUBLINGUAL DRUG DELIVERY 
SYSTEM 
 Although this site is not well suited to sustained delivery 
Systems. 
  Sublingual medication cannot be used when a patient 
is unconscious. 
 Sublingual administration of drugs interferes with eating, 
drinking, and talking, this route is generally considered 
unsuitable for prolonged administration. 
METHOD OF PREPARATION OF SUBLINGUAL 
FORMULATIONS 
Sublingual tablets 
Various techniques can be used to formulate sublingual tablets. 
Direct compression is one of the techniques which require 
the incorporation of a superdisintegrant into the formulation, or 
the use of highly water‐soluble excipients to achieve fast 
tablet disintegration. Direct compression does not require 
the use of water or heat during the formulation procedure 
and is the ideal method for moisture and heat‐labile 
medications. Conventional equipment, commonly available 
excipients and a limited number of processing steps are 
involved in direct compression. Also high doses can be 
accommodated and final weight of tablet can easily exceed 
that of other production methods. Directly compressible 
tablet's disintegration and solubilization depends on 
single or combined action of disintegrats, water soluble 
excipients and effervescent agent. Disintegration efficacy is 
strongly affected by tablet size and hardness. Large and hard tablets 
have disintegration time more than that usually required. As 
consequences, products with optimal disintegration 
properties often have medium to small size and/or high friability 
and low hardness.11, 12. 
Films 
Solvent casting is a process which comprises of casting a dope 
from a casting die onto a casting support, drying the cast dope 
on the casting support form film, stripping off the film from the 
casting support, and further drying the film while conveying the 
film with carrying it at both side edges of the film by a pin tenter, 
wherein residual volatile component content of both side 
edges of the film being carried by the pin tenter is from 30 
mass % to 320 mass% of solid matter at the beginning of being 
cared by the pin tenter13. Solvent Evaporation technique can 
also be used instead of solvent casting for the preparation of 
sublingual films. Sublingual sprays are also in trend which 
improves the time to reach maximum plasma concentration as 
compared to other types of sublingual dosage forms. E.g. in 
case of oxycodone, maximum plasma concentrations is 
reached within 20 minutes when compared with immediate 
release oral tablets (1.3 hours), intramuscular (1 hour),and 
intranasal oxycodone (0.42 hour) in healthy volunteers14. 
EVALUATION PARAMETER 
General appearance: 
The general appearance of a tablet, its visual identity and over all 
"elegance" is essential for consumer acceptance. Include in are 
tablet's size, shape, colour, presence or absence of an odour, 
taste, surface texture, physical flaws and consistency and 
legibility of any identifying marking.15 
Water absorption ratio 
A piece of tissue paper folded twice is placed in a small Petri dish 
Containing 6 ml of water. A tablet is put on the tissue paper 
and allowed to completely wet.The wetted tablet is then 
weighted. Water absorption ratio, R was determined using 
following equation. 
R = 100 × Wa –Wb/Wa 
Where, 
Wa = Weight of tablet after water absorption 
Wb = Weight of tablet before water absorption. 16 
Disintegration test 
The test was carried out on 6 tablets using the apparatus 
specified in I.P. 1996 distilled water at 37ºC ± 2ºC was used as a 
disintegration media and the time in second taken for 
complete disintegration of the tablet with no palable mass 
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remaining in the apparatus was measured in seconds. 17 
Drug Content 
Randomly ten tablets are selected from formulation, finely 
powdered and powder equivalent mg of drug is accurately 
weighed and transferred to 100 ml volumetric flasks containing 
solution of desired pH. The flask is shaken to mix the contents 
thoroughly. The volume is made up to the mark with solution and 
filtered. One ml of the filtrate is suitably diluted and drug 
content is estimated using a double beam UV-visible 
spectrophotometer. This procedure is repeated thrice and 
the average value is calculated. 18 
 
 
In-vitro dissolution studies 
Dissolution study was carried out in USP paddle type apparatus 
using 300 mL of stimulated salivary fluid (pH 6.8) as a 
dissolution medium at 50 rpm. Temperature of the dissolution 
medium was maintained at 37±0.5ºC. Samples of 5ml were 
withdrawn at every 4 minute interval, filtered (through 0.45μ) 
and replaced with 5ml of fresh dissolution medium. The 
samples were suitably diluted and estimated 
spectrophotometrically at 276 nm by using ELICO- 164 
double beam UV-Visible spectrophotometer. The dissolution 
experiments were conducted in triplicate. Dissolution rate 
was studied for all designed formulations and dissolution 
parameters were calculated. 19 
 
DRUGS ADMINISTERED BY SUBLINGUAL ROUTE 
Table 1: Some marketed sublingual tablets 
 
`  
Table 2: Drugs used in the formulation of sublingual dosage forms 
 
 
 
 
Labhade et al                                                                                                        Journal of Drug Delivery & Therapeutics. 2019; 9(3):684-688 
ISSN: 2250-1177                                                                                     [687]                                                                                    CODEN (USA): JDDTAO 
CONTRIBUTION 
Table 3: Contribution in the field of Sublingual Medications 
 
 
CONCLUSION 
Recently many drugs have been formulated for sublingual drug 
delivery with an objective of rapid drug release and restricting 
the region of drug release to mouth. Compared to commonly 
used tablets, capsules and other oral dosage forms, sublingual 
absorption is generally much faster and more efficient. 
Sublingual dosages are convenient for young children, the 
elderly and patients with swallowing difficulties, and in 
situations where potable liquids are not available. Peak blood 
levels of most products administered sublingually are 
achieved within 10‐15 minutes, which is generally much faster 
than when those same drugs are ingested orally. Sublingual 
absorption is efficient. The percent of each dose absorbed is 
generally higher than that achieved by means of oral 
ingestion. Various types of sublingual dosage forms are 
available in market like tablets, films and sprays. 
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